Abstract
The pharmacokinetics, biological effects and distribution in blood and organs of 125I-labeled (1→3)-β-D-glucan purified from Candida albicans were analyzed in rabbits during the 24-h period following an intravenous administration.The intravascular half-life of (1→3)-β- D-glucan was 1.8 min in the low-dose group (9.3 μg/kg) and 1.4 min in the high-dose group (222 μg/kg), and the mean (±SD) total body clearance was 1.12 ± 0.30 and 1.17 ± 0.16 ml/min, respectively. The rabbits remained well and (1→3)-β-D-glucan failed to alter blood cell counts. Less than 3% of the 125I-(1→3)-β-D-glucan was initially associated with the cellular compartment, and this value decreased further during the 2-h period following administration (P = 0.0001). Over 97% of 125I-(1→3)-β-D-glucan was associated with cell-free plasma, and the majority in plasma appeared to be present in the unbound form (not associated with lipoproteins or plasma proteins). The liver contained more than 80% of the 125I-(1→3)-β-D-glucan detected in the six major organs analyzed.
Full Text
The Full Text of this article is available as a PDF (220.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Elstad M. R., Parker C. J., Cowley F. S., Wilcox L. A., McIntyre T. M., Prescott S. M., Zimmerman G. A. CD11b/CD18 integrin and a beta-glucan receptor act in concert to induce the synthesis of platelet-activating factor by monocytes. J Immunol. 1994 Jan 1;152(1):220–230. [PubMed] [Google Scholar]
- Obayashi T., Yoshida M., Tamura H., Aketagawa J., Tanaka S., Kawai T. Determination of plasma (1-->3)-beta-D-glucan: a new diagnostic aid to deep mycosis. J Med Vet Mycol. 1992;30(4):275–280. doi: 10.1080/02681219280000361. [DOI] [PubMed] [Google Scholar]